Bank of America’s Fibrocell Science Inc. FCSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-395
| Closed | -$1K | – | 7665 |
|
|
2019
Q3 | $1K | Buy |
+395
| New | +$811 | ﹤0.01% | 7206 |
|
|
2019
Q2 | – | Sell |
-600
| Closed | -$1K | – | 7588 |
|
|
2019
Q1 | $1K | Hold |
600
| – | – | ﹤0.01% | 7035 |
|
|
2018
Q4 | $1K | Buy |
600
+504
| +525% | +$1.01K | ﹤0.01% | 7039 |
|
|
2018
Q3 | $0 | Buy |
96
+94
| +4,700% | +$203 | ﹤0.01% | 7594 |
|
|
2018
Q2 | $0 | Sell |
2
-12
| -86% | -$35 | ﹤0.01% | 7476 |
|
|
2018
Q1 | $0 | Buy |
+14
| New | +$46 | ﹤0.01% | 7464 |
|
|
2016
Q3 | – | Sell |
-566
| Closed | -$10K | – | 7500 |
|
|
2016
Q2 | $10K | Buy |
+566
| New | +$17.6K | ﹤0.01% | 6507 |
|
|
2016
Q1 | – | Sell |
-591
| Closed | -$40K | – | 7507 |
|
|
2015
Q4 | $40K | Buy |
591
+585
| +9,750% | +$42K | ﹤0.01% | 6142 |
|
|
2015
Q3 | $0 | Sell |
6
-39
| -87% | -$3.45K | ﹤0.01% | 7544 |
|
|
2015
Q2 | $4K | Buy |
+45
| New | +$3.03K | ﹤0.01% | 6917 |
|
|
2014
Q4 | – | Sell |
-809
| Closed | -$35K | – | 8126 |
|
|
2014
Q3 | $35K | Sell |
809
-5,110
| -86% | -$239K | ﹤0.01% | 6750 |
|
|
2014
Q2 | $354K | Buy |
5,919
+5,911
| +73,888% | +$330K | ﹤0.01% | 4968 |
|
|
2014
Q1 | $1K | Sell |
8
-600
| -99% | -$46.5K | ﹤0.01% | 7674 |
|
|
2013
Q4 | $37K | Buy |
608
+593
| +3,953% | +$34.5K | ﹤0.01% | 6738 |
|
|
2013
Q3 | $1K | Sell |
15
-1,741
| -99% | -$141K | ﹤0.01% | 7778 |
|
|
2013
Q2 | $161K | Buy |
+1,756
| New | +$145K | ﹤0.01% | 5826 |
|
Bank of America's FCSC Position: Q4 2019 in Review
Bank of America sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 395 shares — an estimated $1K sold.
Bank of America first reported a position in FCSC in Q2 2013 and held it in 16 quarters. The position peaked at $354K in Q2 2014. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.
- Bank of America reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
- Bank of America sold 395 Fibrocell Science Inc. shares in Q4 2019, an estimated $1K.
- Bank of America first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 16 quarters.
- Bank of America's Fibrocell Science Inc. position peaked at $354K in Q2 2014.
- 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.
Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.